• 1
    Coverdale S, Byth K, Field J, Liddle C, Lin R, Farrell GC. Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. Heptology 1995; 22: 10651071.
  • 2
    Marcellin P, Martinot M, Poteau M, Castelnau C, Boyer N, Descombes I, Le Breton V, et al. Hepatitis C virus genotype and pretreatment serum hepatitis C virus RNA level are the main and independent prognosis factors of sustained response to interferon in chronic hepatitis C [Abstract]. Hepatology 1994; 20: 208.
  • 3
    Chemello L, Cavalletto L, Noventa F, Bonetti P, Casarin C, Bernardinello E, Pontisso P, et al. Predictors of sustained response, relapse and non response in chronic hepatitis C treated with interferon a. Journal of Viral Hepatitis 1995; 2: 9196.
  • 4
    Ballardini G, Groff P, Giostra F, Francesconi R, Zauli D, Lenzi M, Cassani F, et al. Hepatocellular expression of HLA–A, B, C molecules predicts primary response to interferon in patients with chronic hepatitis C. Am J Clin Pathol 1994; 102: 746751.
  • 5
    Vesell ES. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clin Pharmacol Ther 1979; 26: 275286.
  • 6
    Bircher J. Quantitative assessment of deranged hepatic function: a missed opportunity. Semin Liver Dis 1983; 3: 275284.